All stock lists
Summit Therapeutics Inc. (SMMT)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
14.55-0.92 (-5.95%)
Insider Score
––Not scored
SMMT Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SMMT analyst forecast
SMMT analyst consensus
Hold6 ratings
Buy 2 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SMMT 12-month price target
$34.17+134.7% upsideaverage of 6 firms
$41.00High
$25.00Low
Best analysts covering SMMT
- Stifel100%success rate · 1 call
- Citigroup33%success rate · 3 calls
- HC Wainwright & Co.29%success rate · 14 calls
- Jefferies0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SMMT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-01 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-09-29 |
| Goldman Sachs | — | $41.00 | +164.9% | — | 2026-09-29 | |
| Jefferies | — | $30.00 | +93.8% | — | 2026-09-29 | |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-09-23 |
| — | Jefferies | Buy | — | — | Upgraded | 2026-09-09 |
| Summit Redstone Partners | — | $25.00 | +44.7% | — | 2026-09-09 | |
| UBS | — | $33.00 | +91.0% | — | 2026-09-08 | |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-08-26 |
| — | Bernstein | Market Perform | — | — | Upgraded | 2026-08-25 |
| Summit Redstone Partners | — | $11.90 | -6.5% | — | 2026-08-25 | |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-08-18 |
| — | Leerink Partners | Market Perform | — | — | Upgraded | 2026-08-12 |
| — | Stifel | Buy | — | — | Reiterated | 2026-07-24 |
| Guggenheim | Buy | $38.00 | +153.7% | Reiterated | 2026-07-24 | |
| Stifel Nicolaus | — | $38.00 | +153.7% | — | 2026-07-24 | |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-07-23 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-05-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-04 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-05-01 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-08 |
| — | Jefferies | Hold | — | — | Downgraded | 2026-03-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-02-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-02-02 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-01-30 |
| — | Barclays | Equal Weight | — | — | Upgraded | 2025-12-17 |
| Summit Redstone Partners | — | $18.00 | +4.5% | — | 2025-12-17 | |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-10-22 |
| — | Barclays | Underweight | — | — | Reiterated | 2025-10-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-10-21 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-10-20 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-10-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-08 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-09-08 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-09-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-27 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-19 |
| Summit Redstone Partners | — | $21.00 | -18.3% | — | 2025-08-19 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-15 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-08-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-07-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-06-02 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-05-02 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-04-28 |
| Jefferies | Buy | $44.00 | +71.8% | Reiterated | 2025-04-25 | |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-04-23 |
| — | Citigroup | Buy | — | — | Upgraded | 2025-03-26 |
| Summit Redstone Partners | — | $35.00 | +76.0% | — | 2025-03-26 | |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-02-25 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-02-25 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-18 |
| JMP Securities | — | $32.00 | +60.3% | — | 2024-11-04 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-10-31 |
| Summit Redstone Partners | — | $23.00 | +10.1% | — | 2024-09-27 |
SMMT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-23 | -0.10 | -0.29 | $56.8M | $0 |
| 2026-04-30 | -0.33 | -0.24 | $54K | $0 |
| 2026-07-23 | -0.27 | -0.28 | $114K | $0 |
| 2026-10-26 | -0.28 | 0.00 | $71K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.